Product correctly added to cart.

discount label
RuxoRuxolitinib amidelitinib-amide
View 3D

Biosynth logo

RuxoRuxolitinib amidelitinib-amide

CAS: 1911644-32-0

Ref. 3D-IR181199

1mgTo inquire
2mgTo inquire
5mgTo inquire
10mgTo inquire
Estimated delivery in United States, on Monday 26 Aug 2024

Product Information

Name:
RuxoRuxolitinib amidelitinib-amide
Description:

RuxoRuxolitinib amidelitinib-amide is a drug product that is used in the development of new drugs. This synthetic compound has been shown to have cytotoxic activity in vitro and in vivo against cancer cells. The active metabolite of this drug product, desacetylruxolitinib, has been shown to suppress platelet activation and inhibit the growth of erythrocytes. RuxoRuxolitinib amidelitinib-amide is an impurity standard for analytical purposes and an API impurity. It also has been shown to have pharmacological effects on the liver and kidneys, as well as having toxic effects on red blood cells. RuxoRuxolitinib amidelitinib-amide is not found in any pharmacopoeia because it is a synthetic compound.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
324.38 g/mol
Formula:
C17H20N6O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IR181199 RuxoRuxolitinib amidelitinib-amide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".